UnitedHealth Group Incorporated (NYSE:UNH) Position Boosted by City State Bank

City State Bank grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 13.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,645 shares of the healthcare conglomerate’s stock after purchasing an additional 190 shares during the period. City State Bank’s holdings in UnitedHealth Group were worth $872,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the business. Virtus ETF Advisers LLC acquired a new position in shares of UnitedHealth Group in the second quarter worth about $718,000. Arcus Capital Partners LLC boosted its holdings in shares of UnitedHealth Group by 40.1% in the third quarter. Arcus Capital Partners LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,241,000 after buying an additional 703 shares during the period. Mitchell Capital Management Co. boosted its holdings in shares of UnitedHealth Group by 0.7% in the third quarter. Mitchell Capital Management Co. now owns 11,869 shares of the healthcare conglomerate’s stock worth $5,994,000 after buying an additional 78 shares during the period. Regent Investment Management LLC lifted its position in shares of UnitedHealth Group by 0.5% in the third quarter. Regent Investment Management LLC now owns 9,222 shares of the healthcare conglomerate’s stock worth $4,657,000 after purchasing an additional 45 shares in the last quarter. Finally, Secure Asset Management LLC lifted its position in shares of UnitedHealth Group by 1.8% in the third quarter. Secure Asset Management LLC now owns 2,109 shares of the healthcare conglomerate’s stock worth $1,065,000 after purchasing an additional 37 shares in the last quarter. Institutional investors own 86.31% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $2.52 during trading on Friday, reaching $469.50. The stock had a trading volume of 5,289,996 shares, compared to its average volume of 2,955,454. The stock has a fifty day simple moving average of $483.26 and a two-hundred day simple moving average of $510.69. The firm has a market capitalization of $437.97 billion, a price-to-earnings ratio of 22.16, a P/E/G ratio of 1.32 and a beta of 0.69. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 52 week low of $449.70 and a 52 week high of $558.10.

UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings data on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.17 by $0.17. The business had revenue of $82.79 billion for the quarter, compared to the consensus estimate of $82.53 billion. UnitedHealth Group had a net margin of 6.21% and a return on equity of 27.04%. UnitedHealth Group’s quarterly revenue was up 12.3% on a year-over-year basis. During the same quarter last year, the company posted $4.48 earnings per share. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 24.91 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 21st. Stockholders of record on Monday, March 13th will be paid a $1.65 dividend. The ex-dividend date of this dividend is Friday, March 10th. This represents a $6.60 annualized dividend and a dividend yield of 1.41%. UnitedHealth Group’s payout ratio is 31.15%.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on UNH shares. Morgan Stanley reissued an “overweight” rating and issued a $587.00 price target on shares of UnitedHealth Group in a research report on Wednesday, November 23rd. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $615.00 to $617.00 and gave the stock a “buy” rating in a research report on Tuesday, January 24th. StockNews.com raised shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, March 11th. UBS Group cut their price objective on shares of UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 18th. Finally, Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price objective on the stock. in a research report on Monday, November 21st. Three investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $599.68.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.